CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 146 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $227,000 | -78.0% | 32,338 | -74.0% | 0.02% | -73.8% |
| Q1 2022 | $1,033,000 | +275.6% | 124,602 | +206.8% | 0.08% | +200.0% |
| Q4 2021 | $275,000 | +27.9% | 40,610 | 0.0% | 0.03% | +16.7% |
| Q3 2021 | $215,000 | -13.0% | 40,610 | -5.6% | 0.02% | -11.1% |
| Q2 2021 | $247,000 | +118.6% | 43,023 | +74.9% | 0.03% | +170.0% |
| Q1 2021 | $113,000 | +37.8% | 24,592 | 0.0% | 0.01% | +66.7% |
| Q4 2020 | $82,000 | +141.2% | 24,592 | +112.9% | 0.01% | +50.0% |
| Q3 2020 | $34,000 | -93.0% | 11,553 | -89.1% | 0.00% | -90.7% |
| Q2 2020 | $488,000 | +388.0% | 105,702 | +305.3% | 0.04% | +138.9% |
| Q1 2020 | $100,000 | – | 26,080 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |